The Aim of This Study is to Investigate the Correlation Between the Severity of Glaucoma and Corneal Biomechanics as Well as Anterior Chamber Parameters.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06340061

Enrollment

Registered

2024-04-01

Start date

2022-10-20

Completion date

2024-12-31

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

The ocular biomechanical differences between the normal control group and primary glaucoma patients, including those treated with conventional medication, laser therapy, and surgery, were compared. Additionally, an investigation was conducted to explore the relationship between anterior chamber parameters, corneal biomechanics, and the severity of glaucoma

Interventions

OTHERObservational study

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

22 Years to 79 Years

Healthy volunteers

Yes

Inclusion criteria

* Clinical diagnosis of primary glaucoma. * Must be able to cooperate to complete the inspection.

Exclusion criteria

* Secondary glaucoma. * Corneal disease (E. g., keratitis, corneal scarring) that the investigator believes may affect the examination. * trauma * congenital eye malformations

Design outcomes

Primary

Measure	Time frame	Description
IOP	through study completion, an average of 2 years.	Intraocular pressure
bIOP	through study completion, an average of 2 years.	Biomechanical intraocular pressure. Corneal Biomechanics Parameters.
ACD	through study completion, an average of 2 years.	Anterior chamber depth. Anterior Chamber Parameters.
ACW	through study completion, an average of 2 years.	Anterior chamber width. Anterior Chamber Parameters.
SSI	through study completion, an average of 2 years.	Stress-strain index. Corneal Biomechanics Parameters.
VF	through study completion, an average of 2 years.	visual field. The severity of glaucoma is mainly based on the damage of the visual field

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026